Document is current

Any future updates will be listed below

EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s00280-015-2867-8

Published Online: 2015-09-08

Published Print: 2015-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark